Cargando…

Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study

BACKGROUND: The use of metformin after acute myocardial infarction (AMI) has been associated with reduced mortality in people with type 2 diabetes mellitus (T2DM). However, it is not known if it is acutely cardioprotective in patients taking metformin at the time of AMI. We compared patient outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bromage, Daniel I., Godec, Tom R., Pujades-Rodriguez, Mar, Gonzalez-Izquierdo, Arturo, Denaxas, S., Hemingway, Harry, Yellon, Derek M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900858/ https://www.ncbi.nlm.nih.gov/pubmed/31815634 http://dx.doi.org/10.1186/s12933-019-0972-4

Ejemplares similares

Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure
por: Godec, Thomas R., et al.
Publicado: (2022)

Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors
por: Pasea, Laura, et al.
Publicado: (2017)

Neutrophil Counts and Initial Presentation of 12 Cardiovascular Diseases: A CALIBER Cohort Study
por: Shah, Anoop Dinesh, et al.
Publicado: (2017)

How Does Cardiovascular Disease First Present in Women and Men?: Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People
por: George, Julie, et al.
Publicado: (2015)

The pleiotropic effects of metformin: time for prospective studies
por: Bromage, Daniel I, et al.
Publicado: (2015)

Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients
por: George, Julie, et al.
Publicado: (2017)

An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors
por: Gho, Johannes M I H, et al.
Publicado: (2018)

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
por: Shah, Anoop Dinesh, et al.
Publicado: (2015)

The diagnosis, burden and prognosis of dementia: A record-linkage cohort study in England
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2018)

Correction: The diagnosis, burden and prognosis of dementia: A record-linkage cohort study in England
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2018)

Socioeconomic Deprivation and the Incidence of 12 Cardiovascular Diseases in 1.9 Million Women and Men: Implications for Risk Prediction and Prevention
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2014)

Time spent at blood pressure target and the risk of death and cardiovascular diseases
por: Chung, Sheng-Chia, et al.
Publicado: (2018)

Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2015)

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
por: Hausenloy, Derek J, et al.
Publicado: (2013)

Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2018)

Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study
por: Brauer, Ruth, et al.
Publicado: (2015)

Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute
por: Rossello, Xavier, et al.
Publicado: (2018)

Reducing myocardial infarct size: challenges and future opportunities
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

Identification and validation of myocardial infarction and stroke outcomes at scale in UK Biobank
por: Schnier, Christian, et al.
Publicado: (2017)

Emergency department attendance after telephone triage
por: Denaxas, Spiros, et al.
Publicado: (2017)

Natural language processing for disease phenotyping in UK primary care records for research: a pilot study in myocardial infarction and death
por: Shah, Anoop D., et al.
Publicado: (2019)

Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study
por: Herrett, Emily, et al.
Publicado: (2013)

Association between clinical presentations before myocardial infarction and coronary mortality: a prospective population-based study using linked electronic records
por: Herrett, Emily, et al.
Publicado: (2014)

Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
por: Golforoush, Pelin, et al.
Publicado: (2020)

Trends in conventional cardiovascular risk factors and myocardial infarction subtypes among young Chinese men with a first acute myocardial infarction
por: Zhang, Min, et al.
Publicado: (2021)

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
por: Sardu, Celestino, et al.
Publicado: (2019)

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
por: Dondo, Tatendashe B., et al.
Publicado: (2017)

Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study
por: Shah, Anoop Dinesh, et al.
Publicado: (2016)

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
por: Rapsomaniki, Eleni, et al.
Publicado: (2014)

Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population
por: Li, Suying, et al.
Publicado: (2019)

Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction
por: Rapsomaniki, Eleni, et al.
Publicado: (2016)

Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients
por: Bulluck, Heerajnarain, et al.
Publicado: (2017)

Variability in Reassessment of Left Ventricular Ejection Fraction After Myocardial Infarction in the Acute Myocardial Infarction Quality Assurance Canada Study
por: Wilton, Stephen B., et al.
Publicado: (2021)

Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes
por: Herrett, Emily, et al.
Publicado: (2013)

Prognosis of undiagnosed chest pain: linked electronic health record cohort study
por: Jordan, Kelvin P, et al.
Publicado: (2017)

Methods for enhancing the reproducibility of biomedical research findings using electronic health records
por: Denaxas, Spiros, et al.
Publicado: (2017)

Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction
por: Mortensen, Martin Bødtker, et al.
Publicado: (2016)

Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction
por: Wang, Yun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f94c4udgu7i25sfqc9t83pqdm2